Oxford Nanopore Technologies PLC (GB:ONT) has released an update.
Oxford Nanopore Technologies PLC reports a resilient first half in 2024 with a 12.4% revenue growth in constant currency, despite market challenges. The company’s new product launches and strategic collaborations in biopharma and clinical applications are set to bolster long-term growth. With a strong balance sheet and reaffirmed full-year guidance, the company is poised for 20-30% revenue growth in 2024.
For further insights into GB:ONT stock, check out TipRanks’ Stock Analysis page.
